Journal article
Clinical outcomes in relation to the daily dose of recombinant follicle-stimulating hormone for ovarian stimulation in in vitro fertilization in presumed normal responders younger than 39 years: a meta-analysis
Abstract
BACKGROUND: The optimal ovarian stimulation dose to obtain the best balance between the probability of pregnancy and the risk of complications, while maximizing cost-effectiveness of in vitro fertilization (IVF) treatment, is yet to be established.
METHODS: A systematic search of the electronic databases PubMed, EMBASE and Cochrane library, from 1984 until October 2009 for randomized controlled trials comparing different doses of recombinant …
Authors
Sterrenburg MD; Veltman-Verhulst SM; Eijkemans MJC; Hughes EG; Macklon NS; Broekmans FJ; Fauser BCJM
Journal
Human Reproduction Update, Vol. 17, No. 2, pp. 184–196
Publisher
Oxford University Press (OUP)
Publication Date
March 1, 2011
DOI
10.1093/humupd/dmq041
ISSN
1355-4786